Ocera Therapeutics Presents Clinical Data Demonstrating AST-120 Relieves Pruritus In Patients With Liver Cirrhosis At The 60th Annual AASLD Meeting

Ocera Therapeutics, Inc. announced that AST-120 (spherical carbon adsorbent) was shown to reduce the severity of pruritus (itching) in patients with chronic liver disease. The data were presented at the 60th Annual Meeting of the American Association for the Study of Liver Diseases in a presentation titled, "Oral AST-120 (Spherical Carbon Adsorbent) Improves Pruritus and Lowers Serum Bile Acids in Patients with Cirrhosis of Various Etiologies.